Astal Laboratories Limited has filed its quarterly Statement of Deviation and Variation with BSE Limited for the quarter ended 31st December 2025, as required under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The statement was reviewed and approved by the company's Audit Committee and Board of Directors in their meeting held on 14th February 2026.

Fund Raising Details

The company, formerly known as Macro International Limited, raised funds through preferential allotment during the current financial year. The fund raising exercise was completed on 12th August 2025, generating proceeds of Rs. 281.98 lakhs for the company.

Fund Utilization Status

According to the regulatory filing, the company has utilized Rs. 218.10 lakhs out of the total Rs. 281.98 lakhs raised. The funds were deployed for their originally stated objectives without any deviation from the approved purposes.

The original object for fund raising was to meet the long-term funding requirements of the company for capital expenditure, working capital, and general corporate purposes. The company confirmed that there has been no modification to these original objectives.

Regulatory Compliance

The statement confirms that there is no deviation or variation in the use of funds raised from their originally disclosed purposes. Both the Audit Committee and the company's auditors have provided "No Comments" on the fund utilization, indicating compliance with the stated objectives.

The filing was signed by Mahendra Kumar, Company Secretary and Compliance Officer (Membership No. A71224), and submitted from the company's corporate office in Hyderabad. The company operates under CIN L74120UP1993PLC015605 and is listed on BSE with scrip code 512600.

Several companies have submitted their unaudited financial results for the third quarter of FY26, covering the period ended December 31, 2025, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Astal Laboratories Limited Performance

Astal Laboratories Limited reported strong operational performance for Q3 FY26. The company's financial results were approved by the Board of Directors at their meeting held on February 14, 2026.

Coromandel Agro Products and Oils Limited Results

Coromandel Agro Products and Oils Limited, registered in Andhra Pradesh, reported its quarterly performance with total income from operations reaching ₹2,708.80 lakhs for Q3 FY26.

Objective Information Systems Limited Performance

Objective Information Systems Limited, operating in the IT/ITES segment, submitted its unaudited results showing total income from operations of ₹392.58 lakhs for the quarter.

Regulatory Compliance and Publication

All companies have published their financial results in leading newspapers including The Financial Express, The Business Standard, and The Jansatta as required under Regulation 47 of the SEBI regulations. The results have also been made available on respective company websites and BSE's official portal for investor access.

Business Operations Overview

Astal Laboratories operates in manufacturing and trading of active pharmaceutical ingredients, while Coromandel Agro Products focuses on agro-based products and oils. Objective Information Systems operates primarily in the IT services sector. All companies have prepared their financial results in accordance with Indian Accounting Standards (IND AS) prescribed under Section 133 of the Companies Act, 2013.